Navigation Links
CMC Biologics Announces Appointment of New CEO
Date:5/2/2011

COPENHAGEN, Denmark and SEATTLE, May 2, 2011 /PRNewswire/ -- CMC Biologics, a leading biopharmaceutical Contract Manufacturing Organization, with operations in Copenhagen, Denmark and Seattle, Washington USA, announced today that it has hired Claes Glassell to serve at its Chief Executive Officer. CMC Biologics, a company with 370 employees, is committed to delivering  world class, fully integrated, biopharmaceutical process development and manufacturing services.

(Logo:  http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

Claes Glassell brings more than 30 years of industry experience to CMC, most recently as CEO of Cerus Corporation and prior to that as President of Cambrex Corp.

"We are thrilled that Claes has joined the CMC executive team," said David Kauffmann, Chairman of the Board, CMC Biologics, and Managing Director of European Equity Partners. "Claes has been on CMC's board of directors for more than 5 years, and has during that time exhibited a broad range of experience and insight of our industry. Claes' strong leadership qualities and seasoned business understanding makes him the ideal leader to take CMC Biologics to the next level as a leader in our fast moving industry."

"Joining the CMC Executive team at this important time in the Company's lifecycle is a great privilege," said Claes Glassell. "The Company has, despite a very challenging environment in recent years, been successful in continuing to realize strong growth. Today, CMC has a very solid order book demonstrating the strength of the Company's world class service offering, management and science team. CMC is positioned to be a highly successful company."

Claes Glassell joined the CMC board of directors in 2005. Claes left the position as President & CEO of Cerus Corporation, Inc. to take on the position as CEO of CMC Biologics. He is the former President of Cambrex Cor
'/>"/>

SOURCE CMC Biologics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease
2. Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration
3. Pioneer® Surgical Technology, Inc. Enters the Biologics Extremities, Trauma, and General Orthopaedics Market with Legato™ Bone Void Filler
4. DSM Biologics Reports a New Record Achievement with DSMs Proprietary XD® Process Technology with a CHO Cell Line Producing an Fc-fusion Protein:
5. MiMedx Completes Acquisition of Surgical Biologics
6. Avaxia Biologics, Inc. to Present Key Pre-Clinical Inflammatory Bowel Disease Remission Data at Biotech Showcase 2011
7. MiMedx Announces Agreement to Acquire Surgical Biologics
8. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
9. Reportlinker Adds Global Biosimilars (Follow-on biologics) Market: An Analysis
10. EUSA Pharma Submits ERWINASE(R) Biologics License Application (BLA) for Treatment of Acute Lymphoblastic Leukemia
11. Reportlinker Adds Quality for Biologics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Texas , Nov. 21, 2014  World Hemp ... containing low THC, announces they are now offering legal, ... to Charlotte,s Web type strains grown in medical marijuana ... other neurological disorders, such as Parkinson,s, MS, and spinal ... US laws to pass, because imported CBD Oil Is ...
(Date:11/21/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide and ... markets in the United States , ... to acquire 100% of QCR & Trio Diagnostics Limited, ... organization. The transaction closed on November 17, 2014. ...
(Date:11/21/2014)... 2014 Clementia Pharmaceuticals, ... dass die Europäische Arzneimittel-Agentur (European Medicines ... Orphan-Medizinprodukt an Palovarotene vergeben hat, den ... von Fibrodysplasia ossificans progressiva (FOP). FOP ... Krankheit, die von schmerzhaften, wiederkehrenden Episoden ...
Breaking Medicine Technology:New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
... , , LINCOLNSHIRE, Ill. ... leading specialty distributor of health care products in the emergency ... has acquired CVC, Inc.  Headquartered in Arlington, Texas , ... respiratory and emergency medical services markets.   , The privately ...
... , Jan. 12 Stereotaxis (Nasdaq: ... has been approved by the U.S. Food and Drug ... the treatment of Type 1 atrial flutter.  The product ... on-going co-development agreement between Stereotaxis and Biosense Webster to ...
Cached Medicine Technology:Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products 2Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products 3Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter 2Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter 3
(Date:11/24/2014)... 2014 Volpara Solutions announced today ... the 100th Annual Meeting of the Radiology Society ... (RSNA Booth 1752 – South Hall). Volpara Solutions ... the rest of its innovative suite of quantitative ... enable personalized measurements of volumetric density, patient-specific dose, ...
(Date:11/24/2014)... SweetDressy.com, a well-known dress supplier and leader in the ... Dresses. All these fresh items are offered at affordable ... special offer is valid until Dec. 20, 2014. Click ... working well in the fashion industry for years. They ... dresses may be the best products for many ladies ...
(Date:11/24/2014)... SafeHandles™ announced that they will be featured in ... airing via Discovery Channel. Dates and show times TBA. ... replaceable, and affordable germ protective device. This segment will ... adhesives to promote hand hygiene in high traffic and ... is the desire to make a positive impact in ...
(Date:11/23/2014)... The clinical trial report, "Aspergillosis Global ... the Aspergillosis clinical trial scenario. This report provides ... trials on Aspergillosis. It includes an overview of ... per the site of trial conduction across the ... disease clinical trials by their phase, trial status, ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot water ... providing an 8 year warranty on its selected hot water ... up due to the impending winter season, it was important ... premium service that the company provides. As a result, Pro ... Wood and Bradford hot water tanks. , “Every installer ...
Breaking Medicine News(10 mins):Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 2Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 3Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2
... Paramount Acquisition,Corp. (OTC Bulletin Board: PMQC, PMQCU, ... the filing of a third,amendment to the preliminary ... that was originally filed on June 18, 2007. ... meeting of,stockholders to be held to consider the ...
... Rendell,recently appointed Richard Snyder, M.D., senior vice president ... the state,s Chronic Care,Commission. Snyder took his oath ... other commission appointees during its first meeting. ... for Pennsylvanians,living with chronic health conditions such as ...
... Barcelona, Spain: One of the largest individual studies of the ... concluded that it makes no difference whether a woman drinks ... itself (ethyl alcohol) and the quantity consumed that is likely ... risk from drinking three or more alcoholic drinks a day ...
... A new study adds fuel to the debate over whether ... cancer. , The study, presented by Australian ... in Barcelona, found some evidence suggesting exercise might increase the ... study included 24,479 Australian women aged between 27 and 75, ...
... 27 Sagent Pharmaceuticals,Inc., a privately-held specialty ... $53 million Series A financing led by ... used primarily to fund near-term product,launches, product ... development, sales and marketing,manufacturing and distribution partnerships. ...
... Pa., Sept. 26 Kensey Nash Corporation,(Nasdaq: ... Ramius Capital Group,L.L.C. and its affiliates on August ... the,Company,s outstanding common stock, as reported by Ramius ... Control" under the Company,s equity,compensation plan. As a ...
Cached Medicine News:Health News:Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx 2Health News:Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx 3Health News:Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx 4Health News:Governor Rendell Appoints Dr. Richard Snyder of Independence Blue Cross to Chronic Care Commission 2Health News:Governor Rendell Appoints Dr. Richard Snyder of Independence Blue Cross to Chronic Care Commission 3Health News:Wine, women and... spirits, beer and breast cancer risk 2Health News:Wine, women and... spirits, beer and breast cancer risk 3Health News:Study fuels debate over whether exercise and body size influence ovarian cancer risk 2Health News:Study fuels debate over whether exercise and body size influence ovarian cancer risk 3Health News:Sagent Pharmaceuticals Inc. Completes $53 Million Series A Financing 2Health News:Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares 2Health News:Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares 3Health News:Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares 4
... PDCs computer-generated Thermal Printing Wristbands and ... direct thermal and thermal transfer printers. ... activate a heat-sensitive thermal coating under ... printers use heat to transfer highly ...
... Wristbands and Tags print in mere ... transfer printers. Direct thermal printers use ... coating under the bands protective surface. ... transfer highly durable ink from a ...
... coded patient identification bracelets (wristbands) and/or ... at patient care areas throughout the ... identification and in creating a positive ... back to the patient through the ...
... secure band is desired for adults and where an ... appropriate. The design allows for two bands to be ... on the wrist and the second to be held ... This is particularly useful in a hospital situation wherea ...
Medicine Products: